Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KMS MedisurgiBOM:540468 79 EV-to-EBITDA is 47.89 as of Jul. 27, 2026, which is 129% above its 10-year median of 20.90. GuruFocus rates BOM:540468 with a GF Score™ of 79/100 and a GF Value™ of ₹111.52. The stock has 8 warning signs investors should review. Among 510 Medical Devices & Instruments companies, KMS Medisurgi ranks worse than 88.82% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, KMS Medisurgi's enterprise value is ₹434.9 Mil.
KMS Medisurgi's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹9.1 Mil. Therefore, KMS Medisurgi's EV-to-EBITDA for today is 47.89.
The historical rank and industry rank for KMS Medisurgi's EV-to-EBITDA or its related term are showing as below:
BOM:540468'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 11.7 Med: 20.9 Max: 48.16
Current: 47.89
During the past 13 years, the highest EV-to-EBITDA of KMS Medisurgi was 48.16. The lowest was 11.70. And the median was 20.90.
BOM:540468's EV-to-EBITDA is ranked worse than 88.82% of 510
companies
in the Medical Devices & Instruments industry
Industry Median: 14.115
vs BOM:540468: 47.89
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
KMS Medisurgi's PE Ratio (TTM) for today is calculated as:
KMS Medisurgi's share price for today is ₹132.80.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. KMS Medisurgi's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.740.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for KMS Medisurgi's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:540468 vs ISRG, BDX, MDLN: EV-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, KMS Medisurgi's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KMS Medisurgi EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, KMS Medisurgi's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where KMS Medisurgi's EV-to-EBITDA falls into.
KMS Medisurgi's current Enterprise Value is ₹434.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. KMS Medisurgi's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹9.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KMS Medisurgi (BOM:540468) has a EV-to-EBITDA of 47.89 as of Jul. 27, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on KMS Medisurgi. This is 129% above median its historical median of 20.90. Over the past decade, KMS Medisurgi's EV-to-EBITDA has ranged from 11.70 to 48.16. According to the industry distribution chart, KMS Medisurgi ranks #453 out of 510 companies in the Medical Devices & Instruments industry, placing it in the top 88.8%.
Is KMS Medisurgi's EV-to-EBITDA too high?
KMS Medisurgi's current EV-to-EBITDA of 47.89 is 129% above median its 10-year median of 20.90. Over the past 10 years, this metric has ranged from a low of 11.70 to a high of 48.16. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.12. KMS Medisurgi's value of 47.89 is 239.3% above this industry median. Based on the distribution chart, KMS Medisurgi ranks #453 out of 510 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, KMS Medisurgi has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does KMS Medisurgi's EV-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, KMS Medisurgi ranks #453 out of 510 companies for EV-to-EBITDA. This places KMS Medisurgi in the lower half of its industry. The industry median EV-to-EBITDA is 14.12. KMS Medisurgi's value of 47.89 is 239.3% above this benchmark. Historically, KMS Medisurgi's own EV-to-EBITDA has ranged from 11.70 to 48.16 over the past decade. While the company's 10-year median is 20.90 vs. the industry median of 14.12, KMS Medisurgi has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.12, based on 510 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KMS Medisurgi's current EV-to-EBITDA of 47.89 is 239.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on KMS Medisurgi. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KMS Medisurgi's current EV-to-EBITDA is 47.89, which is 129% above median its own 10-year median of 20.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KMS Medisurgi stock overvalued right now?
KMS Medisurgi (BOM:540468) has a current EV-to-EBITDA of 47.89. The stock's GF Value™ is ₹111.52, compared to a current price of ₹132.80 — trading 19.1% above its estimated fair value. The current EV-to-EBITDA is 47.89, which is 129% above median its 10-year median of 20.90 and 239.3% above the Medical Devices & Instruments industry median of 14.12. KMS Medisurgi's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For KMS Medisurgi (BOM:540468), the current EV-to-EBITDA is 47.89 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KMS Medisurgi (BOM:540468) Overvalued in 2026?
Based on GuruFocus' analysis, KMS Medisurgi stock appears to be overvalued.
The current stock price of ₹132.80 is trading 19.1% above its estimated GF Value™ of ₹111.52.
Key valuation signals for BOM:540468:
EV-to-EBITDA: 47.89 (129% above median its 10-year median of 20.90)
GF Value™: ₹111.52 vs. price of ₹132.80 (19.1% above fair value)
Industry Position: 239.3% above the Medical Devices & Instruments median (#453 of 510)
No single metric tells the full story. See the BOM:540468 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KMS Medisurgi Ltd manufactures surgical tapes and dressings for hospitals, institutions, trade associations, exporters, and importers. The company manufactures and undertakes job work of various substartes like non-woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive. The company's international presence includes Vietnam, Dubai, Europe, Australia, Cambodia, India, Africa, Philippines, Russia, Pakistan, Bangladesh, and the USA. The company derives revenue from the sale of goods.
79GF Score
Get the complete analysis for BOM:540468
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540468 has been successfully added to your 
